Mpox cases were 9.6 times higher among unvaccinated men compared to those who had received two vaccine doses, and 7.4 times higher than in those who had received only the first dose.
In one large nursing home system, booster doses were 88% effective in preventing COVID-related deaths.
The expanded EUA awaits a CDC action and comes amid rising respiratory virus activity heading into the winter holidays.
Infectious disease information from CIDRAP.
COVID-19 discussion & analysis on the latest developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and COVID-19 podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
“The [COVID-19] virus is still in the driver’s seat."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
Report: Pharma firms must boost access for LMICs, R&D for pandemic threats
The report reveals encouraging investments but also persistent COVID-19 vaccine inequity and a nearly vacant pipeline for products to treat or prevent worrisome emerging pathogens.